True risk of fetal/neonatal alloimmune thrombocytopenia in subsequent pregnancies: A prospective observational follow-up study

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 123, Issue 5, 2016, Pages 738-744

  Tiller, H ^a,b   Husebekk, A ^b   Skogen, B ^a,b   Kjeldsen Kragh, J ^c   Kjaer M ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c University and Regional Laboratories Region Skåne ^*  (Sweden)

Author keywords

Alloimmunisation; anti HPA 1a; FNAIT; immune thrombocytopenia; natural course; neonatal thrombocytopenia

Indexed keywords

HUMAN PLATELET ANTIGEN 1A ANTIBODY; THROMBOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; BRAIN HEMORRHAGE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETAL INTRACRANIAL HEMORRHAGE; FETUS; FETUS DEATH; FOLLOW UP; GESTATIONAL AGE; HUMAN; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; NEWBORN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; THROMBOCYTE COUNT; MALE; NORWAY; STATISTICAL MODEL;

ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; MALE; MODELS, STATISTICAL; NORWAY; PREGNANCY; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 84924092066     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.13343     Document Type: Article

References (17)

1. Mueller-Eckhardt C, Kiefel V, Grubert A, Kroll H, Weisheit M, Schmidt S, et al., 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989; 1: 363-6.
2. Williamson LM, Hackett G, Rennie J, Palmer CR, Maciver C, Hadfield R, et al., The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood 1998; 92: 2280-7.
3. Radder CM, Brand A, Kanhai HH,. Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it? Vox Sang 2003; 84: 318-25.
4. Rayment R, Brunskill SJ, Stanworth S, Soothill PW, Roberts DJ, Murphy MF,. Antenatal interventions for fetomaternal alloimmune thrombocytopenia. Cochrane Database Syst Rev 2005;(1): CD004226.
5. Bussel J,. Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia. J Thromb Haemost 2009; 7 (Suppl 1): 253-7.
6. Kanhai HH, Porcelijn L, Engelfriet CP, Reesink HW, Panzer S, Ulm B, et al., Management of alloimmune thrombocytopenia. Vox Sang 2007; 93: 370-85.
7. Murphy MF, Bussel JB,. Advances in the management of alloimmune thrombocytopenia. Br J Haematol 2007; 136: 366-78.
8. Kamphuis MM, Oepkes D,. Fetal and neonatal alloimmune thrombocytopenia: prenatal interventions. Prenat Diagn 2011; 31: 712-9.
9. Bussel JB, Zabusky MR, Berkowitz RL, McFarland JG,. Fetal alloimmune thrombocytopenia. N Engl J Med 1997; 337: 22-6.
10. Tiller H, Kamphuis MM, Flodmark O, Papadogiannakis N, David AL, Sainio S, et al., Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registry. BMJ Open 2013; 3:pii: e002490. doi: 10.1136/bmjopen-2012-002490.
11. Kjeldsen-Kragh J, Killie MK, Tomter G, Golebiowska E, Randen I, Hauge R, et al., A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood 2007; 110: 833-9.
12. Killie MK, Husebekk A, Kaplan C, Taaning E, Skogen B,. Maternal human platelet antigen-1a antibody level correlates with the platelet count in the newborns: a retrospective study. Transfusion 2007; 47: 55-8.
13. Bugert P, McBride S, Smith G, Dugrillon A, Kluter H, Ouwehand WH, et al., Microarray-based genotyping for blood groups: comparison of gene array and 5′-nuclease assay techniques with human platelet antigen as a model. Transfusion 2005; 45: 654-9.
14. Rayment R, Brunskill SJ, Soothill PW, Roberts DJ, Bussel JB, Murphy MF,. Antenatal interventions for fetomaternal alloimmune thrombocytopenia. Cochrane Database Syst Rev 2011;(5): CD004226.
15. Kumpel BM, Sibley K, Jackson DJ, White G, Soothill PW,. Ultrastructural localization of glycoprotein IIIa (GPIIIa, beta 3 integrin) on placental syncytiotrophoblast microvilli: implications for platelet alloimmunization during pregnancy. Transfusion 2008; 48: 2077-86.
16. Kjeldsen-Kragh J, Ni H, Skogen B,. Towards a prophylactic treatment of HPA-related foetal and neonatal alloimmune thrombocytopenia. Curr Opin Hematol 2012; 19: 469-74.
17. Pacheco LD, Berkowitz RL, Moise KJ, Bussel JB, McFarland J, Saade GR,. Fetal and neonatal alloimmune thrombocytopenia. A management algorithm based on risk stratification. Obstet Gynecol 2012; 118: 1157-63.